Bard’s Longfield Will Leave In 2003; Board To Begin CEO Search In January
This article was originally published in The Gray Sheet
Executive Summary
Bard Chairman and CEO William Longfield says he will identify "at least one internal candidate" to succeed him in 2003. Bard's board of directors will begin the official search for a replacement in January
You may also be interested in...
Bard Resets Course As Versed Independent, Calls Off Merger With Tyco
C.R. Bard says that it does not expect out-of-pocket costs related to the aborted merger with Tyco International to exceed $10 mil
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.